- Home
- CRVS vs VVR Comparison
CRVS vs VVR Comparison
Compare CRVS & VVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVS
- VVR
- Stock Information
- Founded
- CRVS 2014
- VVR 1998
- Country
- CRVS United States
- VVR United States
- Employees
- CRVS N/A
- VVR N/A
- Industry
- CRVS Biotechnology: Pharmaceutical Preparations
- VVR Trusts Except Educational Religious and Charitable
- Sector
- CRVS Health Care
- VVR Finance
- Exchange
- CRVS Nasdaq
- VVR Nasdaq
- Market Cap
- CRVS 305.4M
- VVR 544.1M
- IPO Year
- CRVS 2016
- VVR N/A
- Fundamental
- Price
- CRVS $4.03
- VVR $3.83
- Analyst Decision
- CRVS Strong Buy
- VVR
- Analyst Count
- CRVS 4
- VVR 0
- Target Price
- CRVS $15.00
- VVR N/A
- AVG Volume (30 Days)
- CRVS 1.2M
- VVR 692.2K
- Earning Date
- CRVS 08-05-2025
- VVR 01-01-0001
- Dividend Yield
- CRVS N/A
- VVR 11.38%
- EPS Growth
- CRVS N/A
- VVR N/A
- EPS
- CRVS N/A
- VVR N/A
- Revenue
- CRVS N/A
- VVR N/A
- Revenue This Year
- CRVS N/A
- VVR N/A
- Revenue Next Year
- CRVS N/A
- VVR N/A
- P/E Ratio
- CRVS N/A
- VVR N/A
- Revenue Growth
- CRVS N/A
- VVR N/A
- 52 Week Low
- CRVS $1.75
- VVR $3.55
- 52 Week High
- CRVS $10.00
- VVR $4.38
- Technical
- Relative Strength Index (RSI)
- CRVS 50.43
- VVR 64.16
- Support Level
- CRVS $3.55
- VVR $3.58
- Resistance Level
- CRVS $4.09
- VVR $3.83
- Average True Range (ATR)
- CRVS 0.31
- VVR 0.05
- MACD
- CRVS -0.03
- VVR 0.01
- Stochastic Oscillator
- CRVS 49.14
- VVR 100.00
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).
About VVR Invesco Senior Income Trust (DE)
Invesco Senior Income Trust is a diversified, closed-end management investment company. The investment objective of the company is to provide a high level of current income, consistent with the preservation of capital. The company invests in a portfolio of interests in floating or variable senior loans to corporations, partnerships, and other entities which operate in a variety of industries and geographic regions.